Ebenbichler C F, Sturm W, Gänzer H, Bodner J, Mangweth B, Ritsch A, Sandhofer A, Lechleitner M, Föger B, Patsch J R
Universitätsklinik für Innere Medizin, Universität Innsbruck, Innsbruck, Austria.
Atherosclerosis. 2001 Oct;158(2):483-90. doi: 10.1016/s0021-9150(01)00465-8.
Self-administration of anabolic-androgenic steroids to increase muscular strength and lean body mass has been used widely among athletes. Flow mediated dilatation (FMD) determined by ultrasound of the brachial artery is accepted as both an in vivo index of endothelial function and an indicator for future atherosclerosis. FMD was calculated in 20 male non-smoking body builders in different phases of their training cycle and in six male non-smoking control athletes. Ultrasound studies of the brachial artery were performed according to the protocol of Celermajer et al. Of the entire training cycle, work-out phase was training phase without actual intake of anabolic-androgenic steroids over 8 weeks; build-up phase included actual intake of anabolic-androgenic steroids; and competition phase consisted of 8 weeks post intake of anabolic-androgenic steroids. Baseline characteristics did not differ between body builder groups except for a higher weight in competition phase body builders. Hormonal analysis revealed suppressed luteinizing hormone and follicle stimulating hormone levels in build-up phase body builders. The lipid profiles showed a marked reduction of HDL-C in build-up phase body builders. FMD was reduced in body builders of all phases when compared to control athletes (work-out phase: 2.5+/-2.7%; build-up phase: 2.1+/-3.0%; competition phase: 0.4+/-2.9% vs. 10.9+/-4.4%, P<0.05 by pairwise comparison using Scheffe's test for work-out phase, build-up phase and competition phase vs. control athletes). The glyceryl trinitrate-induced vasodilatation was diminished, though not statistically significantly, in body builders when compared with control athletes. The differences in FMD persisted after adjustment for vessel size. Our data indicate that intake of anabolic-androgenic steroids is associated with both an atherogenic blood lipid profile and endothelial dysfunction and thus may pose an increased risk of atherosclerosis.
运动员中广泛使用合成代谢雄激素类固醇自我给药以增加肌肉力量和瘦体重。通过肱动脉超声测定的血流介导的扩张(FMD)被认为是内皮功能的体内指标以及未来动脉粥样硬化的指标。对20名处于训练周期不同阶段的男性非吸烟健美运动员和6名男性非吸烟对照运动员计算FMD。根据Celermajer等人的方案进行肱动脉超声研究。在整个训练周期中,锻炼阶段是连续8周不实际摄入合成代谢雄激素类固醇的训练阶段;增肌阶段包括实际摄入合成代谢雄激素类固醇;比赛阶段包括摄入合成代谢雄激素类固醇后8周。健美运动员组之间的基线特征没有差异,除了比赛阶段的健美运动员体重较高。激素分析显示增肌阶段的健美运动员促黄体生成素和促卵泡激素水平受到抑制。血脂谱显示增肌阶段的健美运动员高密度脂蛋白胆固醇显著降低。与对照运动员相比,所有阶段的健美运动员FMD均降低(锻炼阶段:2.5±2.7%;增肌阶段:2.1±3.0%;比赛阶段:0.4±2.9% 对比 10.9±4.4%,使用Scheffe检验进行两两比较,锻炼阶段、增肌阶段和比赛阶段与对照运动员相比P<0.05)。与对照运动员相比,健美运动员中硝酸甘油诱导的血管扩张有所减弱,尽管无统计学意义。在调整血管大小后,FMD的差异仍然存在。我们的数据表明,摄入合成代谢雄激素类固醇与致动脉粥样硬化的血脂谱和内皮功能障碍有关,因此可能增加动脉粥样硬化的风险。